• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道癌中成熟 microRNAs 的不同甲基化水平。

Distinct methylation levels of mature microRNAs in gastrointestinal cancers.

机构信息

Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Department of Cancer Profiling Discovery/ Medical Data Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

出版信息

Nat Commun. 2019 Aug 29;10(1):3888. doi: 10.1038/s41467-019-11826-1.

DOI:10.1038/s41467-019-11826-1
PMID:31467274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6715669/
Abstract

The biological significance of micro (mi)RNAs has traditionally been evaluated according to their RNA expression levels based on the assumption that miRNAs recognize and regulate their targets in an unvarying fashion. Here we show that a fraction of mature miRNAs including miR-17-5p, -21-5p, and -200c-3p and let-7a-5p harbor methyl marks that potentially alter their stability and target recognition. Importantly, methylation of these miRNAs was significantly increased in cancer tissues as compared to paired normal tissues. Furthermore, miR-17-5p methylation level in serum samples distinguished early pancreatic cancer patients from healthy controls with extremely high sensitivity and specificity. These findings provide a basis for diagnostic strategies for early-stage cancer and add a dimension to our understanding of miRNA biology.

摘要

miRNAs 的生物学意义传统上是根据它们的 RNA 表达水平来评估的,这是基于 miRNA 以不变的方式识别和调节其靶标这一假设。在这里,我们发现一部分成熟的 miRNAs 包括 miR-17-5p、-21-5p、-200c-3p 和 let-7a-5p 具有甲基化标记,这些标记可能改变它们的稳定性和靶标识别。重要的是,与配对的正常组织相比,这些 miRNAs 在癌症组织中的甲基化水平显著增加。此外,血清样本中 miR-17-5p 的甲基化水平可以区分早期胰腺癌患者和健康对照者,具有极高的灵敏度和特异性。这些发现为早期癌症的诊断策略提供了依据,并为我们理解 miRNA 生物学增加了一个维度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/f921b4924737/41467_2019_11826_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/515720897681/41467_2019_11826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/cc5808f7a857/41467_2019_11826_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/e2e813d7d800/41467_2019_11826_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/f921b4924737/41467_2019_11826_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/515720897681/41467_2019_11826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/cc5808f7a857/41467_2019_11826_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/e2e813d7d800/41467_2019_11826_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c698/6715669/f921b4924737/41467_2019_11826_Fig4_HTML.jpg

相似文献

1
Distinct methylation levels of mature microRNAs in gastrointestinal cancers.胃肠道癌中成熟 microRNAs 的不同甲基化水平。
Nat Commun. 2019 Aug 29;10(1):3888. doi: 10.1038/s41467-019-11826-1.
2
MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.MTUS1及其靶向的微小RNA在结直肠癌中的显著关联
Tumour Biol. 2016 May;37(5):6637-45. doi: 10.1007/s13277-015-4550-4. Epub 2015 Dec 7.
3
Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.胃癌患者血浆 miRNA 和长链非编码 RNA 的共表达谱分析。
Gene. 2019 Mar 1;687:135-142. doi: 10.1016/j.gene.2018.11.034. Epub 2018 Nov 14.
4
Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.血浆 miRNAs 在胰腺癌的诊断和预后中的作用:一项 miRNA 表达分析。
Gene. 2018 Oct 5;673:181-193. doi: 10.1016/j.gene.2018.06.037. Epub 2018 Jun 18.
5
Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.循环 miRNA-21-5p 作为胰腺癌的诊断生物标志物:来自综合 miRNA 表达谱分析和临床验证的证据。
Sci Rep. 2017 May 10;7(1):1692. doi: 10.1038/s41598-017-01904-z.
6
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.作为肺癌早期诊断潜在生物标志物的微小RNA差异表达谱
Oncol Rep. 2017 Jun;37(6):3543-3553. doi: 10.3892/or.2017.5612. Epub 2017 Apr 28.
7
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.DNA甲基化导致12种癌症相关微小RNA的失调及乳腺癌进展。
Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18.
8
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.卵巢癌中异常甲基化调控的新型 miRNA 基因参与转移。
Gene. 2018 Jul 1;662:28-36. doi: 10.1016/j.gene.2018.04.005. Epub 2018 Apr 6.
9
Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.血浆 microRNAs 作为早期胃癌早期检测的潜在新型生物标志物。
World J Gastroenterol. 2019 Apr 7;25(13):1580-1591. doi: 10.3748/wjg.v25.i13.1580.
10
MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.用于诊断胰腺癌和胆管癌的微小RNA标志物。
PLoS One. 2015 Feb 23;10(2):e0118220. doi: 10.1371/journal.pone.0118220. eCollection 2015.

引用本文的文献

1
Noncoding RNA and Alcohol Use Disorder: A Scoping Review of Current Research and Knowledge Gaps.非编码RNA与酒精使用障碍:当前研究及知识空白的范围综述
Alcohol Res. 2025 Jun 20;45(1):06. doi: 10.35946/arcr.v45.1.06. eCollection 2025.
2
Chemically modified non-coding RNAs in cancer.癌症中的化学修饰非编码RNA
Expert Rev Mol Med. 2025 Jun 9;27:e19. doi: 10.1017/erm.2025.10007.
3
Novel insights into the N 6-methyladenosine modification on circRNA in cancer.对癌症中环状RNA上N6-甲基腺苷修饰的新见解。

本文引用的文献

1
Significant epitranscriptomes in heterogeneous cancer.异质性癌症中的重要表观转录组学
Cancer Sci. 2019 Aug;110(8):2318-2327. doi: 10.1111/cas.14095.
2
The identification and characterization of non-coding and coding RNAs and their modified nucleosides by mass spectrometry.通过质谱法对非编码RNA和编码RNA及其修饰核苷进行鉴定和表征。
RNA Biol. 2014;11(12):1568-85. doi: 10.4161/15476286.2014.992280.
3
The dynamic epitranscriptome: N6-methyladenosine and gene expression control.动态表观转录组:N6-甲基腺苷和基因表达调控。
Front Oncol. 2025 May 19;15:1554888. doi: 10.3389/fonc.2025.1554888. eCollection 2025.
4
Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics.近期对尿液或血液外泌体中隐藏的实体癌生物标志物的探索,这些生物标志物为未来癌症诊断提供基础信息。
Diagnostics (Basel). 2025 Mar 5;15(5):628. doi: 10.3390/diagnostics15050628.
5
Multichrome encoding-based multiplexed, spatially resolved imaging reveals single-cell RNA epigenetic modifications heterogeneity.基于多色编码的多路复用、空间分辨成像揭示了单细胞RNA表观遗传修饰的异质性。
Nat Commun. 2025 Jan 22;16(1):958. doi: 10.1038/s41467-025-56331-w.
6
: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potential.调节作用、癌症相关信号通路破坏及治疗潜力。
Expert Opin Ther Targets. 2024 Dec;28(12):1061-1091. doi: 10.1080/14728222.2024.2433687. Epub 2024 Dec 8.
7
Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma.人源微小RNA-3665启动子甲基化作为食管鳞状细胞癌预后潜在生物标志物的发现与验证
Int J Clin Oncol. 2025 Feb;30(2):309-319. doi: 10.1007/s10147-024-02656-3. Epub 2024 Dec 4.
8
Recent advances in methylation modifications of microRNA.微小RNA甲基化修饰的最新进展
Genes Dis. 2023 Dec 23;12(1):101201. doi: 10.1016/j.gendis.2023.101201. eCollection 2025 Jan.
9
Emerging roles of bases modifications and DNA repair proteins in onco-miRNA processing: novel insights in cancer biology.碱基修饰和DNA修复蛋白在肿瘤微小RNA加工中的新作用:癌症生物学的新见解
Cancer Gene Ther. 2024 Dec;31(12):1765-1772. doi: 10.1038/s41417-024-00836-x. Epub 2024 Sep 25.
10
The roles and mechanisms of coding and noncoding RNA variations in cancer.编码和非编码RNA变异在癌症中的作用及机制
Exp Mol Med. 2024 Sep;56(9):1909-1920. doi: 10.1038/s12276-024-01307-x. Epub 2024 Sep 2.
Nat Rev Mol Cell Biol. 2014 May;15(5):313-26. doi: 10.1038/nrm3785. Epub 2014 Apr 9.
4
Quantitative analysis of ribonucleoside modifications in tRNA by HPLC-coupled mass spectrometry.通过高效液相色谱-质谱联用技术对转运RNA中的核糖核苷修饰进行定量分析。
Nat Protoc. 2014 Apr;9(4):828-41. doi: 10.1038/nprot.2014.047. Epub 2014 Mar 13.
5
Role of tRNA modifications in human diseases.tRNA 修饰在人类疾病中的作用。
Trends Mol Med. 2014 Jun;20(6):306-14. doi: 10.1016/j.molmed.2014.01.008. Epub 2014 Feb 25.
6
Clinical relevance of circulating cell-free microRNAs in cancer.循环细胞游离 microRNAs 在癌症中的临床相关性。
Nat Rev Clin Oncol. 2014 Mar;11(3):145-56. doi: 10.1038/nrclinonc.2014.5. Epub 2014 Feb 4.
7
N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells.N6-甲基腺苷修饰使胚胎干细胞中的发育调控因子失稳。
Nat Cell Biol. 2014 Feb;16(2):191-8. doi: 10.1038/ncb2902. Epub 2014 Jan 7.
8
A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation.一个 METTL3-METTL14 复合物介导了哺乳动物核 RNA N6-腺苷酸甲基化。
Nat Chem Biol. 2014 Feb;10(2):93-5. doi: 10.1038/nchembio.1432. Epub 2013 Dec 6.
9
N6-methyladenosine-dependent regulation of messenger RNA stability.N6-甲基腺苷依赖的信使 RNA 稳定性调控。
Nature. 2014 Jan 2;505(7481):117-20. doi: 10.1038/nature12730. Epub 2013 Nov 27.
10
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq.m6A-seq 揭示的人类和小鼠 m6A RNA 甲基组学图谱。
Nature. 2012 Apr 29;485(7397):201-6. doi: 10.1038/nature11112.